Seres Therapeutics
MCRB· Manufacturing· Fiscal year ends in December
No proxy on file names the CEO of Seres Therapeutics.
Executives5
See all- 1Eric D. ShaffFormer President and Chief Executive OfficerFY2025
- 2Thomas J. DesRosierFormer Co-President and Co-Chief Executive Officer and current Executive Vice President and Chief Legal OfficerFY2025
- 3Marella ThorellFormer Co-President and Co-Chief Executive Officer and current Executive Vice President and Chief Financial OfficerFY2025
- 4Teresa L. Young, Ph.D.Former Executive Vice President and Chief Commercial and Strategy OfficerFY2025
- 5Matthew Henn, Ph.D.President and Chief Scientific OfficerFY2025
Named executives and their total pay, from the Summary Compensation Table of the latest proxy.
Pay
See allSeres Therapeutics paid its 5 named executives $6.1M in total in FY2025 (Dec).
| Name | |||
|---|---|---|---|
| Eric D. ShaffFormer President and Chief Executive Officer | |||
| Thomas J. DesRosierFormer Co-President and Co-Chief Executive Officer and current Executive Vice President and Chief Legal Officer | Not disclosed | ||
| Marella ThorellFormer Co-President and Co-Chief Executive Officer and current Executive Vice President and Chief Financial Officer | Not disclosed | Not disclosed | |
| Teresa L. Young, Ph.D.Former Executive Vice President and Chief Commercial and Strategy Officer | Not disclosed | ||
| Matthew Henn, Ph.D.President and Chief Scientific Officer | Not disclosed | Not disclosed |
of each named executive, from the Summary Compensation Table of each proxy.
Peers18
See allThe comes from the company's proxy. CEO pay and of each company come from its own Pay versus Performance table for the same fiscal year.
Board3
See all- Willard H. Dere, M.D.Director · 8 yr on the boardIndependentAudit (Chair), Science and Clinical Development—Paid as an executive
- Kurt C. GravesDirector · 4 yr on the boardIndependentCompensation and Talent (Chair)—Paid as an executive
- Robert RosielloDirector · 0 yr on the boardIndependentCompensation and Talent—Paid as an executive
The board of the latest proxy (FY2025).
Activity
Filings6
See all| Proxy statement | DEF 14A | Apr 27, 2026 | FY2025 |
| Annual report | 10-K | Mar 12, 2026 | FY2025 |
| Annual report | 10-K | Mar 13, 2025 | FY2024 |
| Proxy statement | DEF 14A | Mar 13, 2025 | FY2024 |
| Annual report | 10-K | Mar 5, 2024 | FY2023 |
| Proxy statement | DEF 14A | Mar 5, 2024 | FY2023 |